1 / 8 Brokerage firm Kotak Securities in a note on Tuesday, April 1, wrote that they still do not find value in most parts of the market. They also do not rule out further earnings downgrades over the next few months. It has cited Q4 results as a critical aspect for the market over […]
Trump Reciprocal Tariffs: These Indian Pharma companies are likely to be impacted – CNBC TV18
April 2 is the day that Donald Trump’s proposed reciprocal tariffs kick in, even as the world awaits an official announcement on the scope and quantum of tariffs from the US President. A sector in the line of fire is Pharma, as majority of Indian Pharma exports head to the US. However, the White House […]
Stocks to Watch on March 21: Manappuram Finance, Hindalco, Bajaj Finance, TVS Motor and more – CNBC TV18
1 / 10 Manappuram Finance | The company announced a preferential allotment of equity shares and warrants worth ₹4,385 crore to Bain Capital, marking a significant investment by the global private equity firm. The board of Manappuram Finance approved the issuance of 9.29 crore equity shares at ₹236 per share to BC Asia Investments XXV […]
Piramal Pharma arm gets nod to market paediatric infusion Neoatricon in UK – CNBC TV18
Drug firm Piramal Pharma Ltd on Thursday (March 20) said Piramal Critical Care (PCC) and Ireland-based BrePco Biopharma Ltd (BPCO) have received UK Medicines and Healthcare Products Regulatory Agency (MHRA) approval for Naeoatricon, the first paediatric-strength dopamine hydrochloride infusion for treating hypotension in neonates, infants, and children. Piramal Critical Care has secured commercialisation rights for […]
Stocks to Watch on February 19: RVNL, L&T, CONCOR, Infosys and more – CNBC TV18
1 / 9 RVNL | State-owned company said it has received a letter of acceptance from Rail Infrastructure Development Company (Karnataka) Ltd (K-RIDE) for the construction of nine stations under Corridor-4A of the Bengaluru Suburban Rail Project (BSRP). The ₹554.47-crore contract involves building one elevated and eight at-grade stations at Heelalige, Singena Agrahara, Huskur, Ambedkar […]
Piramal Pharma’s Mumbai facility gets 6 observations from US FDA inspection – CNBC TV18
Pharmaceutical firm Piramal Pharma Ltd on Tuesday (February 18) announced that the US FDA conducted a general GMP (Good Manufacturing Practice) inspection at its Turbhe, Navi Mumbai, facility between February 11-17, 2025. The inspection concluded with a Form 483 issued, containing six observations. Company Value Change %Change “This is to inform you that the US […]
Piramal Pharma Q3 Results | Net profit tanks 63% to ₹4 crore, revenue climbs 13% to ₹2,204 crore – CNBC TV18
Piramal Pharma Ltd on Tuesday (January 28) reported a 63.4% year-on-year (YoY) decline in net profit at ₹3.7 crore for the third quarter that ended December 31, 2024. Company Value Change %Change In the corresponding quarter of the previous fiscal, Piramal Pharma posted a net profit of ₹10.1 crore, the company said in a regulatory filing. The company’s […]
Piramal Pharma’s critical care division launches Chlorpromazine injection in US – CNBC TV18
Piramal Pharma Ltd on Wednesday (January 22) said its division Piramal Critical Care (PCC) has announced the US launch of Chlorpromazine Hydrochloride for Injection, USP. The product will be available in two vial formats—25 mg/1 mL and 50 mg/2 mL—marking an expansion of PCC’s generic injectables portfolio. Company Value Change %Change The launch of Chlorpromazine […]
Top five Pharma stocks to bet on for 2025, according to Motilal Oswal Wealth – CNBC TV18
1 / 8 Brokerage firm Motilal Oswal Wealth Management wrote in a note that India’s Pharma industry is likely to grow between 9% to 11% in financial year 2026, citing a report by CRISIL. The growth will be led by price hikes and new launches in the domestic market and a rise in export demand […]
Top Buy Calls: These stocks may surge up to 50% as per analysts – CNBC TV18
SUMMARY From MTAR Tech to Motilal Oswal, analysts have projected potential upside of up to 50% for these stocks going forward. 1 / 7 There have been a slew of coverage initiations over the course of this week with analysts projecting stocks to rise anywhere between 25% to 50% over the course of the next […]